In last trading session, T2 Biosystems Inc (NASDAQ:TTOO) saw 0.33 million shares changing hands with its beta currently measuring 0.28. Company’s recent per share price level of $3.90 trading at -$0.32 or -7.58% at ring of the bell on the day assigns it a market valuation of $13.03M. That closing price of TTOO’s stock is at a discount of -5310.0% from its 52-week high price of $210.99 and is indicating a discount of -6.15% from its 52-week low price of $4.14. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.33 million shares which gives us an average trading volume of 818.97K if we extend that period to 3-months.
For T2 Biosystems Inc (TTOO), analysts’ consensus is at an average recommendation of a Hold while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$2.79 in the current quarter.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Upright in the red during last session for losing -7.58%, in the last five days TTOO remained trading in the red while hitting it’s week-highest on Wednesday, 11/15/23 when the stock touched $3.90 price level, adding 17.55% to its value on the day. T2 Biosystems Inc’s shares saw a change of -97.25% in year-to-date performance and have moved -17.37% in past 5-day. T2 Biosystems Inc (NASDAQ:TTOO) showed a performance of -31.16% in past 30-days. Number of shares sold short was 0.34 million shares which calculate 0.38 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $5.35 to the stock, which implies a rise of 27.1% to its current value. Analysts have been projecting $5.35 as a low price target for the stock while placing it at a high target of $5.35. It follows that stock’s current price would drop -37.18% in reaching the projected high whereas dropping to the targeted low would mean a loss of -37.18% for stock’s current value.
T2 Biosystems Inc (TTOO) estimates and forecasts
This year revenue growth is estimated to fall -64.60% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $2.4 million for the same. And 2 analysts are in estimates of company making revenue of $3.55 million in the next quarter that will end on Mar 2024. Company posted $5.48 million and $2.08 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -56.20% while estimating it to be 70.80% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 33.92% during past 5 years.
T2 Biosystems Inc is more likely to be releasing its next quarterly report on October 12 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
Gsa Capital Partners Llp is the top institutional holder at TTOO for having 40351.0 shares of worth $0.28 million. And as of Jun 29, 2023, it was holding 0.01% of the company’s outstanding shares.